Hajime Toguchi

3.1k total citations
61 papers, 2.6k citations indexed

About

Hajime Toguchi is a scholar working on Pharmaceutical Science, Molecular Biology and Oncology. According to data from OpenAlex, Hajime Toguchi has authored 61 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pharmaceutical Science, 15 papers in Molecular Biology and 13 papers in Oncology. Recurrent topics in Hajime Toguchi's work include Advanced Drug Delivery Systems (18 papers), Drug Solubulity and Delivery Systems (12 papers) and Nanoparticle-Based Drug Delivery (10 papers). Hajime Toguchi is often cited by papers focused on Advanced Drug Delivery Systems (18 papers), Drug Solubulity and Delivery Systems (12 papers) and Nanoparticle-Based Drug Delivery (10 papers). Hajime Toguchi collaborates with scholars based in Japan and United States. Hajime Toguchi's co-authors include Hiroaki Okada, Yasuaki Ogawa, Toshiro Heya, Yasuaki Ogawa, Masateru Miyake, Kazutaka Higaki, Masaaki Odomi, Toshikiro Kimura, T. Mukai and Hiroaki Okada and has published in prestigious journals such as Biomaterials, Journal of Controlled Release and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Hajime Toguchi

61 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hajime Toguchi Japan 26 1.4k 688 633 262 245 61 2.6k
Kazuhiro Morimoto Japan 32 1.4k 1.0× 996 1.4× 550 0.9× 323 1.2× 182 0.7× 132 3.3k
A. A. Hıncal Türkiye 26 1.3k 1.0× 551 0.8× 764 1.2× 284 1.1× 185 0.8× 77 2.4k
Hiromitsu Yamamoto Japan 23 1.4k 1.0× 735 1.1× 715 1.1× 227 0.9× 104 0.4× 47 2.4k
Shinji Sakuma Japan 29 1.1k 0.8× 713 1.0× 402 0.6× 249 1.0× 404 1.6× 103 2.4k
Christiane Damgé France 25 1.2k 0.9× 671 1.0× 559 0.9× 186 0.7× 158 0.6× 55 2.3k
Maria Immacolata La Rotonda Italy 32 1.3k 0.9× 847 1.2× 707 1.1× 532 2.0× 269 1.1× 72 3.4k
Yasuaki Ogawa Japan 24 764 0.6× 758 1.1× 493 0.8× 302 1.2× 256 1.0× 48 2.5k
Jaber Emami Iran 29 922 0.7× 713 1.0× 643 1.0× 341 1.3× 180 0.7× 80 2.5k
Young Wook Choi South Korea 33 1.5k 1.1× 894 1.3× 529 0.8× 324 1.2× 178 0.7× 133 3.1k
Gian Paolo Zara Italy 27 1.1k 0.8× 1.0k 1.5× 596 0.9× 309 1.2× 253 1.0× 46 2.4k

Countries citing papers authored by Hajime Toguchi

Since Specialization
Citations

This map shows the geographic impact of Hajime Toguchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hajime Toguchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hajime Toguchi more than expected).

Fields of papers citing papers by Hajime Toguchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hajime Toguchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hajime Toguchi. The network helps show where Hajime Toguchi may publish in the future.

Co-authorship network of co-authors of Hajime Toguchi

This figure shows the co-authorship network connecting the top 25 collaborators of Hajime Toguchi. A scholar is included among the top collaborators of Hajime Toguchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hajime Toguchi. Hajime Toguchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kamada, Naoki, Masateru Miyake, Keigo Yamada, et al.. (2008). In vitro–in vivo correlation for wet-milled tablet of poorly water-soluble cilostazol. Journal of Controlled Release. 130(1). 29–37. 58 indexed citations
2.
Miyake, Masateru, Hajime Toguchi, Masaaki Odomi, et al.. (2006). Importance of bile acids for novel oral absorption system containing polyamines to improve intestinal absorption. Journal of Controlled Release. 115(2). 130–133. 20 indexed citations
3.
Miyake, Masateru, Naoki Kamada, Yoshikazu Oka, et al.. (2004). Development of suppository formulation safely improving rectal absorption of rebamipide, a poorly absorbable drug, by utilizing sodium laurate and taurine. Journal of Controlled Release. 99(1). 63–71. 21 indexed citations
5.
6.
Sato, Jun, et al.. (1994). Pharmacokinetic Alteration in Rats of Recombinant Interleukin-2 (rIL-2) by Immunocomplexing with a Monoclonal Antibody against rIL-2.. Biological and Pharmaceutical Bulletin. 17(4). 535–538. 6 indexed citations
7.
Heya, Toshiro, Hiroaki Okada, Yasuaki Ogawa, & Hajime Toguchi. (1994). In Vitroandin VivoEvaluation of Thyrotrophin Releasing Hormone Release from Copoly (dl‐lactic/glycolic acid) Microspheres. Journal of Pharmaceutical Sciences. 83(5). 636–640. 51 indexed citations
8.
Heya, Toshiro, et al.. (1994). Controlled Release of Thyrotropin Releasing Hormone from Microspheres: Evaluation of Release Profiles and Pharmacokinetics after Subcutaneous Administration. Journal of Pharmaceutical Sciences. 83(6). 798–801. 23 indexed citations
9.
Akiyama, Yohko, Minoru Yoshioka, Yoshiyuki Inada, et al.. (1994). Anti-hypertensive Effect of Oral Controlled-release Microspheres Containing an ACE Inhibitor (Delapril Hydrochloride) in Rats. Journal of Pharmacy and Pharmacology. 46(8). 661–665. 10 indexed citations
10.
Okada, Hiroaki, et al.. (1994). Preparation of Three-Month Depot Injectable Microspheres of Leuprorelin Acetate Using Biodegradable Polymers. Pharmaceutical Research. 11(8). 1143–1147. 172 indexed citations
11.
Igari, Yasutaka, et al.. (1993). Sustained release preparation of erythropoietin using sodium hyaluronate.. Drug Delivery System. 8(4). 237–241. 2 indexed citations
13.
Iga, Katsumi, Yasuaki Ogawa, & Hajime Toguchi. (1992). Heat-Induced Drug Release Rate and Maximal Targeting Index of Thermosensitive Liposome in Tumor-Bearing Mice. Pharmaceutical Research. 9(5). 658–662. 22 indexed citations
14.
Okada, Hiroaki, et al.. (1992). Anticancer effects of chemoembolization using microspheres of an angiogenesis inhibitor (TNP-470) in rabbits bearing VX-2 carcinoma.. Drug Delivery System. 7(2). 97–102. 3 indexed citations
15.
Toguchi, Hajime. (1992). Formulation study of leuprorelin acetate to improve clinical performance.. PubMed. 14 Suppl A. 121–30. 10 indexed citations
16.
Iga, Katsumi, et al.. (1991). Increased Tumor Cisplatin Levels in Heated Tumors in Mice after Administration of Thermosensitive, Large Unilamellar Vesicles Encapsulating Cisplatin. Journal of Pharmaceutical Sciences. 80(6). 522–525. 23 indexed citations
17.
Toguchi, Hajime, Yasuaki Ogawa, Hiroaki Okada, & Masaki Yamamoto. (1991). Once-a-Month Injectable Microcapsules of Leuprorelin Acetate. YAKUGAKU ZASSHI. 111(8). 397–409. 10 indexed citations
18.
Ogawa, Yuriko & Hajime Toguchi. (1990). [Targeting therapy with a drug using temperature-sensitive liposomes entrapped antitumor drug together with localized hyperthermia].. PubMed. 17(6). 1127–33. 4 indexed citations
19.
Toguchi, Hajime, Yutaka Ogawa, & Tsugio Shimamoto. (1990). Effects of the physicochemical properties of the emulsion formulation on the bioavailability of ethyl 2-chloro-3-(4-(2-methyl-2-phenylpropyloxy)phenyl) propionate in rats.. Chemical and Pharmaceutical Bulletin. 38(10). 2797–2800. 17 indexed citations
20.
Yamashita, Kenji, et al.. (1986). Evaluation of sustained-release capsules of molsidomine (SIN-10) in dogs and monkeys.. Chemical and Pharmaceutical Bulletin. 34(3). 1257–1263. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026